31
Views
52
CrossRef citations to date
0
Altmetric
Original Article

Nonstandard Antibodies as Prognostic Markers in Autoimmune Hepatitis

, &
Pages 195-201 | Received 14 Nov 2003, Accepted 18 Mar 2004, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Walter EB Sipe & Philip Rosenthal. (2007) Autoimmune hepatitis in children: diagnosis, pathology and treatment. Expert Review of Clinical Immunology 3:2, pages 159-169.
Read now
Albert J Czaja. (2006) The role of autoantibodies as diagnostic markers of autoimmune hepatitis. Expert Review of Clinical Immunology 2:1, pages 33-48.
Read now
Aldo Montano-Loza, Aldo Montano-Loza, Albert J. Czaja, Herschel A. Carpenter, Andrea Piette, Daniel Murphy, Zakera Shums, Rufus Burlingame & Gary L. Norman. (2006) Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis. Autoimmunity 39:4, pages 341-348.
Read now

Articles from other publishers (49)

Ben Flikshteyn, Kamal Amer, Zaid Tafesh & Nikolaos T. Pyrsopoulos. (2024) Diagnosis of Autoimmune Hepatitis. Clinics in Liver Disease 28:1, pages 37-50.
Crossref
Gary L. Norman, Nicola Bizzaro, Danilo Villalta, Diego Vergani, Giorgina Mieli-Vergani, Gideon M. Hirschfield & Michael Mahler. 2021. Precision Medicine and Artificial Intelligence. Precision Medicine and Artificial Intelligence 135 167 .
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad & Albert J. Czaja. (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 72:2, pages 671-722.
Crossref
Petr Urbánek. (2020) Autoimmune hepatitis. Vnitřní lékařství 66:1, pages e11-e18.
Crossref
Kalliopi Zachou, Christina Weiler‐Normann, Luigi Muratori, Paolo Muratori, Ansgar W. Lohse & George N. Dalekos. (2019) Permanent immunosuppression in SLA/LP‐positive autoimmune hepatitis is required although overall response and survival are similar. Liver International 40:2, pages 368-376.
Crossref
Imane Brahim, Ikram Brahim, Raja Hazime & Brahim Admou. (2017) Hépatites auto-immunes : diagnostic immunologique. La Presse Médicale 46:11, pages 1008-1019.
Crossref
Albert J. Czaja. (2017) Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Digestive Diseases and Sciences 62:9, pages 2277-2292.
Crossref
A.J. Czaja. 2017. Liver Pathophysiology. Liver Pathophysiology 61 85 .
Michael P. Manns & Nora Schweitzer. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 521 529 .
Albert J. Czaja. 2017. Liver Disorders. Liver Disorders 217 250 .
Albert J Czaja. (2016) Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut and Liver 10:2, pages 177.
Crossref
Martha M. Kirstein, Frauke Metzler, Elena Geiger, Eyk Heinrich, Michael Hallensleben, Michael P. Manns & Arndt Vogel. (2015) Prediction of short‐ and long‐term outcome in patients with autoimmune hepatitis. Hepatology 62:5, pages 1524-1535.
Crossref
. (2015) EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 63:4, pages 971-1004.
Crossref
Albert J. Czaja. (2015) Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Digestive Diseases and Sciences 60:10, pages 2881-2900.
Crossref
Zhi-Xian Chen, Jian-Guo Shao, Yi Shen, Jian Zhang, Yu Hua, Lu-Jun Wang & Gang Qin. (2015) Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis. Medicine 94:23, pages e953.
Crossref
Kalliopi Zachou, Stella Gampeta, Nikolaos K. Gatselis, Katerina Oikonomou, John Goulis, Menelaos N. Manoussakis, Yves Renaudineau, Dimitrios P. Bogdanos & George N. Dalekos. (2015) Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis. Liver International 35:2, pages 660-672.
Crossref
Albert J. Czaja. (2015) Diagnosis and Management of Autoimmune Hepatitis. Clinics in Liver Disease 19:1, pages 57-79.
Crossref
Junko Yokokawa, Yukiko Kanno, Kazumichi Abe, Hironobu Saito, Kyoko Monoe, Fumiko Katsushima, Natsumi Sakamoto, Atsushi Takahashi, Hirohide Yokokawa & Hiromasa Ohira. (2014) Anti-nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity. Hepatology Research 44:4, pages 420-428.
Crossref
Wen-Chao Zhang, Feng-Rong Zhao, Juan Chen & Wei-Xian Chen. (2014) Meta-Analysis: Diagnostic Accuracy of Antinuclear Antibodies, Smooth Muscle Antibodies and Antibodies to a Soluble Liver Antigen/Liver Pancreas in Autoimmune Hepatitis. PLoS ONE 9:3, pages e92267.
Crossref
Takashi Himoto & Mikio Nishioka. (2013) Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Autoimmunity Highlights 4:2, pages 39-53.
Crossref
Christiane Radzimski, Christian Probst, Bianca Teegen, Kristin Rentzsch, Inga Madeleine Blöcker, Cornelia Dähnrich, Wolfgang Schlumberger, Winfried Stöcker, Dimitrios P. Bogdanos & Lars Komorowski. (2013) Development of a Recombinant Cell-Based Indirect Immunofluorescence Assay for the Determination of Autoantibodies against Soluble Liver Antigen in Autoimmune Hepatitis. Clinical and Developmental Immunology 2013, pages 1-7.
Crossref
Catherine Johanet, Elvire Beleoken & Eric Ballot. (2012) Autoantibodies in autoimmune hepatitis: Antinuclear antibodies (ANA). Clinics and Research in Hepatology and Gastroenterology 36:4, pages 394-396.
Crossref
Catherine Johanet & Eric Ballot. (2012) Auto-antibodies in autoimmune hepatitis: Anti-soluble liver antigen (SLA). Clinics and Research in Hepatology and Gastroenterology 36:3, pages 244-246.
Crossref
Albert J. Czaja. (2011) Autoantibody-Negative Autoimmune Hepatitis. Digestive Diseases and Sciences 57:3, pages 610-624.
Crossref
Nora Schweitzer & Michael P. Manns. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 565 578 .
Albert J. Czaja. (2011) Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults. Digestive Diseases and Sciences 56:12, pages 3421-3438.
Crossref
C. Johanet & E. Ballot. (2011) Anticorps anti-antigènes solubles du foie (anti-SLA) et hépatites auto-immunes. Immuno-analyse & Biologie Spécialisée 26:3, pages 118-124.
Crossref
Carole Émile. (2011) Les anticorps anti-antigènes solubles du foie (anti-SLA). Option/Bio 22:453, pages 20-21.
Crossref
Albert J. Czaja. (2010) Autoantibodies as Prognostic Markers in Autoimmune Liver Disease. Digestive Diseases and Sciences 55:8, pages 2144-2161.
Crossref
Albert J. Czaja & Michael P. Manns. (2010) Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology 139:1, pages 58-72.e4.
Crossref
C. Johanet & E. Ballot. (2010) Autoanticorps en hépatologie. EMC - Hépatologie 5:2, pages 1-10.
Crossref
Albert J. Czaja. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 1461 1476.e2 .
Violaine Eyraud, Olivier Chazouilleres, Eric Ballot, Christophe Corpechot, Raoul Poupon & Catherine Johanet. (2009) Significance of antibodies to soluble liver antigen/liver pancreas: a large French study. Liver International 29:6, pages 857-864.
Crossref
Albert J. Czaja. (2008) Genetic Factors Affecting the Occurrence, Clinical Phenotype, and Outcome of Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 6:4, pages 379-388.
Crossref
Diego Vergani & Giorgina Mieli-Vergani. (2008) Autoimmune Hepatitis and PSC Connection. Clinics in Liver Disease 12:1, pages 187-202.
Crossref
William Bernal, Yun Ma, Heather M. Smith, Bernard Portmann, Julia Wendon & Diego Vergani. (2007) The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study. Journal of Hepatology 47:5, pages 664-670.
Crossref
Edwin Liu & George S. Eisenbarth. (2007) Accepting clocks that tell time poorly: Fluid-phase versus standard ELISA autoantibody assays. Clinical Immunology 125:2, pages 120-126.
Crossref
Aldo J. Montano-Loza, Herschel A. Carpenter & Albert J. Czaja. (2007) Improving the End Point of Corticosteroid Therapy in Type 1 Autoimmune Hepatitis to Reduce the Frequency of Relapse. The American Journal of Gastroenterology 102:5, pages 1005-1012.
Crossref
Aldo J. Montano-Loza, Herschel A. Carpenter & Albert J. Czaja. (2007) Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver International 27:4, pages 507-515.
Crossref
Catherine Johanet, Stéphanie Huguet-Jacquot, Violaine Eyraud & Eric Ballot. (2006) Auto-anticorps et pathologies hépatiques. Revue Francophone des Laboratoires 2006:387, pages 25-33.
Crossref
C. Cazanave, S. Rakotondravelo, P. Morlat, P. Blanco, F. Bonnet & J. Beylot. (2006) Hépatite auto-immune chez une patiente co-infectée VIH-VHC : difficultés diagnostiques et thérapeutiques. La Revue de Médecine Interne 27:5, pages 414-419.
Crossref
Michael P. Manns & Arndt Vogel. (2006) Autoimmune Hepatitis, From Mechanisms to Therapy. Hepatology 43:Supplement 1, pages S132-S144.
Crossref
J de SezeV Canva-Delcambre, I Fajardy, S Delalande, T Stojkovic, E Godet & P Vermersch. (2016) Autoimmune hepatitis and multiple sclerosis: a coincidental association?. Multiple Sclerosis Journal 11:6, pages 691-693.
Crossref
Jean-Charles Duclos-Vallée, Eric Ballot, Stéphanie Huguet & Catherine Johanet. (2005) Hépatites autoimmunes. Gastroentérologie Clinique et Biologique 29:12, pages 1236-1243.
Crossref
Albert J Czaja. (2005) Autoimmune liver disease. Current Opinion in Gastroenterology 21:3, pages 293-299.
Crossref
Albert J. Czaja. (2005) Current concepts in autoimmune hepatitis. Annals of Hepatology 4:1, pages 6-24.
Crossref
Albert J. Czaja. 2005. 127 164 .
A. J. Czaja. 2005. Autoimmune Liver Disease. Autoimmune Liver Disease 153 170 .
Albert J. Czaja, Francesco B. Bianchi, Herschel A. Carpenter, Edward L. Krawitt, Ansgar W. Lohse, Michael P. Manns, Ian G. McFarlane, Giorgina Mieli-Vergani, Gotaro Toda, Diego Vergani, John Vierling & Mikio Zeniya. (2005) Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 41:1, pages 207-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.